ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,654Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 127

$1.56M Total Retail Price of All Prescriptions

Rank: 3 out of 127

483 Patients Receiving at Least One Drug in Part D
7%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

10% of this provider’s 789 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
RISPERIDONE 1,180 112 1 2
TRAZODONE HCL 797 21 2 1
TRIHEXYPHENIDYL HCL 782 13 R 10 3 29
MIRTAZAPINE 684 45 4 11
SERTRALINE HCL 666 46 5 6
BENZTROPINE MESYLATE 659 37 R 6 12
GABAPENTIN 655 0 7 16
FLUOXETINE HCL 554 0 8 10
CHLORPROMAZINE HCL 501 16 10 9 42
PRAZOSIN HCL 484 0 10 10 54
HYDROXYZINE PAMOATE 462 15 R 11 14
CITALOPRAM HBR 461 27 12 3
PROPRANOLOL HCL 426 27 10 13 36
LAMOTRIGINE 408 0 14 5
ABILIFY 396 31 15 7
DOXEPIN HCL 395 0 16 37
HALOPERIDOL 393 12 17 34
ZOLPIDEM TARTRATE 376 35 18 4
LITHIUM CARBONATE 316 27 19 23
DIVALPROEX SODIUM ER 279 21 20 21
AMANTADINE 262 41 21 63
QUETIAPINE FUMARATE 239 0 22 9
DIVALPROEX SODIUM 233 26 23 24
VALPROIC ACID 231 13 24 59
CYMBALTA 224 0 25 8
OLANZAPINE 198 12 26 13
VENLAFAXINE HCL ER 192 0 27 17
INVEGA SUSTENNA 185 0 28 38
BUPROPION HCL SR 183 13 29 26
CLOZAPINE 182 0 30 25
ZIPRASIDONE HCL 157 16 31 30
CARBAMAZEPINE 155 25 32 45
HALOPERIDOL DECANOATE 147 0 33 79
FLUPHENAZINE HCL 147 0 33 50
AMITRIPTYLINE HCL 135 12 R 35 40
BUSPIRONE HCL 131 0 36 20
PAROXETINE HCL 122 18 37 22
OXCARBAZEPINE 118 0 38 31
RISPERDAL CONSTA 111 0 39 41
TOPIRAMATE 96 0 40 32
LATUDA 88 0 41 51
SEROQUEL 83 0 42 33
LOXAPINE 78 13 43 109
CLONIDINE HCL 70 0 44 44
THIORIDAZINE HCL 58 0 R 45 97
VENLAFAXINE HCL 55 0 46 85
FLUVOXAMINE MALEATE 52 0 47 103
FLUPHENAZINE DECANOATE 51 19 48 111
PERPHENAZINE 50 0 49 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.